Does METILDIGOXIN Cause Dyspnoea? 42 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Dyspnoea have been filed in association with METILDIGOXIN. This represents 38.9% of all adverse event reports for METILDIGOXIN.
42
Reports of Dyspnoea with METILDIGOXIN
38.9%
of all METILDIGOXIN reports
0
Deaths
28
Hospitalizations
How Dangerous Is Dyspnoea From METILDIGOXIN?
Of the 42 reports, 28 (66.7%) required hospitalization, and 2 (4.8%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METILDIGOXIN. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does METILDIGOXIN Cause?
Bradycardia (28)
Dizziness (18)
Off label use (17)
Wound haemorrhage (16)
Drug interaction (15)
General physical health deterioration (15)
Decreased appetite (14)
Medication error (14)
Pleural effusion (14)
Therapeutic product effect decreased (14)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which METILDIGOXIN Alternatives Have Lower Dyspnoea Risk?
METILDIGOXIN vs METOCLOPRAMIDE
METILDIGOXIN vs METOLAZONE
METILDIGOXIN vs METOPIMAZINE
METILDIGOXIN vs METOPROLOL
METILDIGOXIN vs METRELEPTIN